SPNS1 Activators are chemical agents that specifically enhance the functional activity of SPNS1, a sphingosine-1-phosphate (S1P) transporter. The activation of SPNS1 is facilitated by compounds that alter the S1P signaling and its gradient across cellular membranes. For instance, Sphingosine-1-phosphate itself, being a substrate for SPNS1, can directly boost its transport function by binding to SPNS1 and increasing the efficiency of S1P transfer to the extracellular space. Similarly, FTY720, once phosphorylated, mimics S1P's actions and augments SPNS1 activity by enhancing the cellular export of S1P. Inhibition of S1P1 receptor by ML056 leads to a build-up of intracellular S1P, which then relies on SPNS1 for its export, thereby indirectly increasing the transporter's functionalactivity. SEW2871 and W146, by modulating S1P1 receptor activity, can influence the intracellular S1P levels and thus indirectly affect SPNS1's role in S1P egress. In a similar vein, CAY10444, VPC23019, JTE013, CYM50308, and CYM50358 each target different S1P receptors, but all contribute to the modulation of the S1P gradient, which is critically maintained by SPNS1's transport function. By antagonizing these receptors, these compounds can enhance SPNS1 activity by necessitating increased S1P transport to restore the disturbed S1P signaling balance.
Moreover, compounds like DOP contribute to the pool of S1P by serving as a precursor in its biosynthesis pathway, indirectly necessitating an upregulation of SPNS1 activity to deal with the increased S1P synthesis. Conversely, SKI-II, by inhibiting sphingosine kinase, prevents the conversion of sphingosine to S1P, which paradoxically can enhance SPNS1 activity as the cell attempts to maintain S1P homeostasis by potentially upregulating the transport machinery. Thus, the activation of SPNS1 is intricately linked to the homeostasis of S1P and its signaling, with these activators playing pivotal roles in ensuring the efficiency and regulation of S1P transport across cellular membranes, thereby maintaining the physiological functions that S1P mediates through its receptor-mediated signaling pathways.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator that can enhance SPNS1 activity by promoting its transport function. S1P can bind to SPNS1 and facilitate its role in S1P signaling and transport, thus increasing the availability of S1P for receptor-mediated signaling. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a synthetic analog of S1P. Upon phosphorylation, it acts as an agonist at S1P receptors, indirectly enhancing SPNS1 function by increasing intracellular S1P levels, thereby promoting S1P export via SPNS1. | ||||||
SEW2871 | 256414-75-2 | sc-203251 sc-203251A | 5 mg 10 mg | $38.00 $53.00 | 1 | |
SEW2871 is a selective agonist for the S1P1 receptor. It can indirectly increase the activity of SPNS1 by promoting the S1P receptor signaling cascade that can lead to a feedback increase in S1P export. | ||||||
2-undecyl-thiazolidine-4-carboxylic acid | 298186-80-8 | sc-220768 sc-220768A | 5 mg 10 mg | $88.00 $166.00 | ||
CAY10444 is a selective S1P3 receptor antagonist. Blocking S1P3 may alter the intracellular signaling and S1P gradient, thereby enhancing the transport role of SPNS1 in maintaining S1P homeostasis. | ||||||
VPC 23019 | 449173-19-7 | sc-362817 | 10 mg | $364.00 | 4 | |
VPC23019 is an antagonist for S1P1 and S1P3 receptors. It may increase the extracellular S1P levels by preventing receptor-mediated S1P uptake, indirectly enhancing SPNS1-mediated S1P transport. | ||||||
JTE 013 | 383150-41-2 | sc-203615 | 10 mg | $195.00 | 5 | |
JTE013 is a selective S1P2 receptor antagonist. It can lead to changes in the S1P gradient and signaling, thereby potentially enhancing the transport activity of SPNS1. | ||||||
SKI II | 312636-16-1 | sc-204286 sc-204286A | 10 mg 50 mg | $96.00 $400.00 | 3 | |
SKI-II is a sphingosine kinase inhibitor. By inhibiting the phosphorylation of sphingosine to S1P, it can increase sphingosine levels, which may upregulate SPNS1 activity to re-establish S1P homeostasis. | ||||||